When drug regulatory authorities assess applications for marketing authorization, three types of situation need to be distinguished:

(1) Assessment of new active substances, not marketed as prescription medicines and designed specifically for use in self-medication.

(2) Assessment for self-medication of medicinal products hitherto available only on prescription.

(3) Assessment of existing self-medication products that have not previously been evaluated.